Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Baxter
Cantor Fitzgerald
Mallinckrodt
Citi
McKesson

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 7,547,546

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,547,546
Title:Progenitor cells from wharton\'s jelly of human umbilical cord
Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours osteogenic progenitor cells and MHC-/- progenitor cells, and is useful to grow and repair human tissues including bone.
Inventor(s): Davies; John E. (Toronto, CA), Baksh; Dolores (Mississauga, CA), Sarugaser; Rahul (Toronto, CA), Hosseini; Morris (Braunschweig, DE), Lickorish; Antony D. S. (Toronto, CA)
Assignee: Tissue Regeneration Therapeutics Inc. (Toronto, Ontario, CA)
Application Number:10/961,919
Patent Claims:see list of patent claims

Details for Patent 7,547,546

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04 ➤ Try a Free Trial Tissue Regeneration Therapeutics Inc. (Toronto, Ontario, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,547,546

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2004072273 Aug 26, 2004
United States of America 2005148074 Jul 07, 2005
United States of America 2009269318 Oct 29, 2009
United States of America 2013259840 Oct 03, 2013
United States of America 2016032241 Feb 04, 2016
United States of America 2017157180 Jun 08, 2017
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Harvard Business School
AstraZeneca
Accenture
Queensland Health
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.